Skye Bioscience, Inc. Liabilities, Noncurrent
Skye Bioscience, Inc. (SKYE) had Liabilities, Noncurrent of $8.59 million as of 2018-03-31, per its 10-Q filed 2018-05-15.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LiabilitiesNoncurrent · last filed 2018-08-10
- 2018-03-31: Liabilities, Noncurrent $8.59M.
- 2017-12-31: Liabilities, Noncurrent $551.32K.
- 2017-09-30: Liabilities, Noncurrent $791.81K.
- 2017-06-30: Liabilities, Noncurrent $1.07M.
| Period end | Liabilities, Noncurrent |
|---|---|
| 2018-03-31 | $8.59M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $551.32K 10-Q · filed 2018-08-10 |
| 2017-09-30 | $791.81K 10-Q · filed 2017-11-14 |
| 2017-06-30 | $1.07M 10-Q · filed 2017-08-11 |
| 2017-03-31 | $1.10M 10-Q · filed 2017-05-12 |
| 2016-12-31 | $1.11M 10-K · filed 2018-03-19 |
| 2016-09-30 | $869.99K 10-Q · filed 2016-11-09 |
| 2016-06-30 | $845.58K 10-Q · filed 2016-08-12 |
| 2016-03-31 | $2.87M 10-Q · filed 2016-05-13 |
| 2015-12-31 | $2.46M 10-K · filed 2017-03-10 |
| 2015-09-30 | $2.90M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $2.42K 10-Q · filed 2015-08-14 |
| 2015-03-31 | $1.61K 10-Q · filed 2015-05-13 |
| 2014-12-31 | $805.00 10-K · filed 2016-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |